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Abstract
Antigen sub units for vaccine studies are typically isolated from recombinant proteins in an expression system.
However, not all protein expression systems are used to express the specific protein. In this study, we optimized the
pGEX system combined with the modified protein refolding to express and isolate M. tuberculosis proteins, especially
proteins that are expressed as an inclusion body. Resuscitation promoting factor B (RpfB) protein is one of the
Resuscitation promoting factor (Rpf) family of proteins that has been studied for its ability to induce cellular immunity
in animal tests. Silico analyses demonstrate how RpfB is included in cell wall and cell processes. The Rpf family
proteins are promising antigens that can be used as a TB vaccine candidate. The polymerase chain reaction was briefly
performed using specific primers to amplify the full length of the rpfB. PCR amplification products were then purified,
cut by restriction endonucleases, and cloned in to pGEX 6-P1. Protein expression was done in the Escherichia coli
BL21 strain, and expressed protein was isolated using the modified protein refolding and solubilization method. The
complex protein expression that appeared as inclusion bodies were successfully isolated and can be detected as complex
GST-RpfB through the western blotting process. Our study results indicate that this system and our modified method
are suitable for M. tuberculosis inclusion body protein expression and isolation.

Abstrak
Optimasi System Ekspresi pGEX untuk Mengekpresikan dan Mengisolasi Protein RpfB Mycobacterium
tuberculosis dalam Bentuk Badan Inklusi Menggunakan Metode Refolding yang Dimodifikasi. Antigen sub unit
untuk studi vaksin umumnya diisolasi dari protein rekombinan menggunakan suatu sistem ekspresi. Sementara itu, tidak
semua sistem ekspresi protein dapat digunakan untuk mengekspresikan protein tertentu. Dalam studi ini kami
melakukan optimasi sistim pGEX untuk mengekspresikan dan mengisolasi protein M. tuberculosis yang diekspresikan
sebagai badan inklusi. Resuscitation promoting factor B (RpfB) protein adalah salah satu protein keluarga Resuscitation
promoting factor (Rpf) yang telah dipelajari kemampuannya dalam menginduksi imunitas seluler hewan uji. RpfB
protein terlibat dalam pembentukan dinding sel dan proses-proses dalam sel. Protein keluarga Rpf berpotensi sebagai
antigen yang dapat digunakan sebagai kandidat vaksin TB. Secara singkat, reaksi berantai polimerase menggunakan
primer spesifik digunakan untuk mendapatkan panjang DNA sintetik rpfB yang dibutuhkan. Produk amplifikasi PCR
kemudian dimurnikan, dipotong oleh ensim restriksi endonuclease yang dilanjutkan dengan pengklonaan kedalam
pGEX 6-P1. Ekspresi protein dilakukan di bakteri non pathogen Escherichia coli strain BL21, selanjutnya protein
terekspresi diisolasi menggunakan metode refolding dan solubilisasi yang dimodifikasi. Komplek protein yang
terekpresi muncul sebagai badan inklusi dan terdeteksi sebagai komplek GST-RpfB melalui metode western blotting.
Hasil studi menunjukkan sistem pGEX dan modifikasi metode solubilisasi dan refolding dapat mengisolasi protein M.
tuberculosis yang diekspresikan dalam bentuk badan inklusi.
Keywords: Mycobacterium tuberculosis, Beijing strain, RpfB, recombinant protein
ization (WHO) reported that the mortality rate of tuberculosis (TB) disease in Indonesia is about 67,000 cases/year and 2,100 cases/year for TB-HIV [1]. Increasing
TB infections can be prevented by preventative means
such as vaccination. However, the BCG vaccine used

Introduction
Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis and is one of the most serious
health problems in Indonesia. The World Health Organ155
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broadly in the world has variable protective efficacy,
ranging from 0 to 77% [2,3]. The weakness of the BCG
vaccine has led to new vaccine studies with the aim of
determining alternative vaccines to use as primary or
booster vaccines.
The rpf family consists of five genes, i.e. rpfA, B, C, D,
and E, which play a role in inducing the bacteria to
change from a stationary condition to an active growth
condition [4,5]. The experiment results do by some
researchers have shown the capability of this family to
induce antibodies and the cellular immune system in
animal tests [6]. Conversely, further studies reveal that the
RpfB and RpfD proteins stimulated a higher response of
cellular immunity compared to the other proteins in this
family [7]. Both characteristics of the Rpf protein family, the ability to induce stationary bacterial cells and the
ability to generate immune responses, are interesting
study themes for further investigation. Nonetheless,
exploring protein expression systems is necessary as it
continues to be a challenge to find alternative systems
that can be used to express M. tuberculosis proteins.
The aims of this study were to examine the manufacturing
of the recombinant protein of M. tuberculosis, Beijing
strain, from Indonesian patients collected by Pusat Biomedis dan Teknologi Kesehatan Kementrian Kesehatan
Republik Indonesia. The focus was particularly RpfB, in
the pGEX system, and to examine the protein expression
system itself. Several studies demonstrate success in
cloning and in the protein expression of M. tuberculosis
proteins in vector systems, such as the pET system, the
pColdII system, the pGEX system itself, and others [8-10].
Although the pGEX system has been used for protein
expression of M. tuberculosis, information on the pGEX
system is still limited, especially for proteins that have the
potential to be expressed as inclusion bodies. Therefore,
it is necessary for further testing of the pGEX system
with other proteins of M. tuberculosis. The pGEX system
has some advantages compared to other systems. One of
these advantages is the availability of anti-GST, as the
expression of GST fusion proteins can be easily analyzed
using western blotting. Similarly, tools to isolate and
purify the proteins based on GST affinity are available
to simplify and shorten the workflow. The results of this
study provide useful information on use of the pGEX
system, along with useful information on the protocol to
obtain recombinant M. tuberculosis proteins. The RpfB
protein designed and produced in this study can be used
in subsequent studies with the aim of discovering
vaccine candidates that can be produced in Indonesia.

Materials and Methods
Strain. The M. tuberculosis H37Rv strain used in this
study is a bacterial stock from the Department of Microbiology, Medical Faculty, Universitas Indonesia. The
Beijing strain was kindly donated from the Center for
Makara J. Sci.

Biomedical and Health Technology, Ministry of Health
Republic of Indonesia (Pusat Biomedis dan Teknologi
Kesehatan Kementrian Kesehatan Republik, Indonesia).
Genomic DNA extraction. M. tuberculosis genomic DNA
was isolated from the cells using the boiling method
[11]. The bacterial cells were scraped from LowensteinJensen media and inserted into 1.5 mL tubes, containing
500 L sterile dH2O. They were then incubated at 100
C in a heat block for 10 minutes. The tubes were centrifuged to separate genomic DNA from cell debris. The
supernatant containing M. tuberculosis genomic DNA
was isolated and stored at minus 30 C until used.
Amplification of the rpfB gene. The rpfB gene was
amplified using the polymerase chain reaction (PCR)
method with specific primers annealing to the rpfB region (primers used in this study are not published for
patent purposes). The PCR product size was confirmed
by gel electrophoresis and then purified using a PCR
purification kit (Qiagen). The purified PCR product was
then used for cloning.
Cloning of the rpfB gene into the pGEX system and
transformation. pGEX 6-1 and rpfB PCR products
were digested by EcoRI and XhoI restriction enzymes
(Fermentas) and then purified before ligation. The ligation
process was done using T4 DNA ligase (Fermentas),
resulting in plasmid harboring the inserted gene. Transformation of recombinant plasmid into E. coli DH5was
done using the heat shock method and resulted in the
MRB1 and MRB3 strain [12]. The ligation product was
mixed with bacterial competent cells in a 1.5 mL plastic
tube and incubated on ice for 30 minutes, and then incubated under heat shock conditions at 42 C for 1.5
minutes. The bacterial cells were sub cultured in LB
medium and shaken for 1 hour at 37 C. LB agar containing 100 g/mL ampicillin was used to select bacterial cells carrying recombinant plasmid. Plasmids isolated from bacteria growing on the selective medium were
examined for the correct orientation of the inserted gene
by PCR, and for correct base composition by sequencing. The plasmid containing the rpfB gene was then
transformed into E. coli strain BL21 as the expression
host resulting in the MRB2 and MRB4 strain.
RpfB protein expression. Strain MRB2 and MRB4 was
grown on selective media until the optical density
(OD600) reached 0.4, and then IPTG (Isopropyl β-D-1thiogalactopyranoside) was added to a final concentration of 1 mM. Incubation was continued for 4 hours
before bacterial cells were harvested. Ten milliliters of
1x phosphate-buffered saline (PBS) was added to the
bacterial pellet after centrifugation and the re-suspended
pellet was subjected to sonication using a Memert
sonicator. Lysed bacterial cells after sonication was
analyzed by electrophoresis on a 15% SDSDecember 2018 Vol. 22  No. 4
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polyacrylamide gel (SDS-PAGE) to detect the expression of RpfB protein. RpfB protein expression was confirmed by western blotting with anti GST antibody.
Extraction, solubilization, and refolding of recombinant RpfB protein. The pellet, from centrifugation
after sonication, was re-suspended in the lysis buffer
containing lysozyme. Sonication was performed again
for 30 minutes to break down cell membranes and then
subjected for centrifugation at 5000 rpm. This was done
for 10 minutes at 4 °C. Subsequently, the pellet was resuspended in buffer TNMFX — 2M urea containing 50
mM Tris-Base, 150 mM NaCl, 1 mM EDTA, and 2 M
urea — and then subjected to 10 minutes sonication,
followed by centrifugation at 5,000 rpm for 10 minutes
at 4 °C. Pellets were then re-suspended in buffer
TNMFX-0.1% Triton-X100 contained 50 mM Tris, 150
mM NaCl, 1 mM EDTA, and 0.1% Triton-X100. The
suspension was sonicated for 10 minutes, incubated for
30 minutes at 4 C, and then centrifuged at 5000 rpm for
10 minutes. The pellet was re-suspended in the
solubilization buffer, containing 8M urea, then centrifuged at 1000 rpm for 10 minutes at 4 °C. The supernatant was collected and stored at -80 °C until refolding.
For refolding, the supernatant was diluted fivefold in the
refolding buffer containing 50 mM Tris - HCl, 100 Mm
NaCl, 1 mM reduced glutathione, 1 mM DTT, and 1
mM PMSF. The diluted solution was incubated overnight at 4 °C with stirring.
Isolation of recombinant protein RpfB. Refolded recombinant RpfB protein was isolated using the GST
affinity column; this was based on the manufacturer's
instructions. Prior to this, the affinity column was equilibrated with the equilibration buffer containing 50 mM
Tris-HCl, 100 mM NaCl, 1 mM reduced glutathione, 1
mM DTT, and 1 mM PMSF in a volume four times the
volume of the resin. The column was incubated, with
shaking, for one hour and then the equilibration buffer
was removed from the column. A volume of refolding
protein solution, three times the volume of the resin,
was poured into the column and incubated on a shaker
for 1 hour. The liquid in the column was collected in a
sterile tube as the flow through. The column was then
washed 2–3 times with a wash buffer. Recombinant protein bound to the resin was eluted with an elution buffer,
collected in a sterile tube, and stored at -80° until use.

Results and Discussion
In order to construct the AR1 and AR2 plasmids, we
inserted the rpfB gene downstream of the GST sequence, between the multi cloning site (MCS) and the
terminal sequence (Figure 1). Gene insertion in this area
is advantageous because the addition of a terminal sequence to the PCR product is not necessary. With this
construct, expression of a protein in accordance with the
expected length is more likely.
Makara J. Sci.
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Figure 1. Plasmid Construction to Find AR1 Plasmid

The transformation result produced by colony PCR displayed some positive colonies carrying the rpfB gene on
a plasmid. Successful DNA transformation of AR1 and
AR2 plasmid into E. coli BL21 was demonstrated, and
elicited the MRB2 and MRB4 strains. Success of the
transformation was determined by colony PCR results,
which exhibited bands with length as expected (data not
shown). All strains and plasmids used in this study are
listed in Table 1 and Table 2.
Analysis results for the gene sequencing of rpfB gene
M. tuberculosis strains Beijing, from recombinant plasmids, elicited the presence of mutations outside of the
epitopes region when compared to strain H37Rv (Figure 2).
RpfB protein have two epitops for CD4+ cell T (codon
146-160, codon 251-256) and one epitope for CD8+ cell
T (codon 66-80) Based on analysis using Genetyx ver.4
software. Even though mutations occurred in cloning, we
believe that these mutations will not affect the ability of
the protein to stimulate the immune response, since the
mutations are out of epitope regions.
To observe RpfB protein expression in the host, we
cultured MRB2 and MRB4 in a Luria Bertani (LB)
medium. Addition of 1 mM IPTG as an inducer at OD600
0.4 succeeded in inducing RpfB expression, as detected
in SDS PAGE (Figure 3). The length of the RpfB protein
band was as expected based on analysis in silico [13].
Unexpectedly, the expression of RpfB strain from strain
was higher than the H37Rv strain. We speculate that the
appearance of this gene mutation may have resulted
from changes in the protein conformational, a protein
that is normally accepted and overexpressed by E. coli but
was instead rejected. It will be advantageous to isolate the
protein in a large scale. However, this experimental step
revealed that the expression of the Rpf protein family of
M. tuberculosis can be performed in the pGEX system
with E. coli as a host.
December 2018 Vol. 22  No. 4
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Tabel 1. Bacterial Strain List
Strain
M. tuberculosis strain H37Rv

Genotype

M. tuberculosis strain Beijing
E. coli DH5
E. coli BL21pLys
MRB1 (H37Rv)
MRB2 (H37Rv)
MRB3 (Beijing)
MRB4 (Beijing)

FΦ80lacZΔM15Δ(lacZYAargF) U169
recA1 endA1 hsdR17 (rK–, mK+) phoA
supE44 λ– thi-1 gyrA96 relA1
F–ompT hsdS(rB–mB–) gal dcm λ(DE3)
pLysS (Camr) (λ(DE3):lacI, lacUV5-T7
gene 1, ind1, sam7, nin5 )
E. coli DH5pGEX6P-1 rpfB
E.coli BL21pGEX6P-1 rpfB
E. coli DH5pGEX6P-1 rpfB
E.coli BL21pGEX6P-1 rpfB

Source
Bacterial stock of Microbiology Department Medical
Faculty Universitas Indonesia
Bacterial stock of Pusat Biomedis dan Teknologi
Kesehatan Kementrian Kesehatan Republik Indonesia
Bacterial stock of Microbiology Department Medical
Faculty Universitas Indonesia
Bacterial stock of Microbiology Department Medical
Faculty Universitas Indonesia
This work
This work
This work
This work

Table 2. Plasmid List
Plasmid
pGEX 6P-1
R1 (H37Rv)
R2 (Beijing)

Genotype
pGEX 6P-1ΔrpfB
pGEX 6P-1ΔrpfB

Source
Amersham
This work
This work

rpfB M. tuberculosis H37Rv standard
sequence

rpfB M. tuberculosis H37Rv standard
sequence

rpfB M. tuberculosis H37Rv standard
sequence

rpfB M. tuberculosis H37Rv standard
sequence

rpfB M. tuberculosis H37Rv standard
sequence

rpfB M. tuberculosis H37Rv standard
sequence

rpfB M. tuberculosis H37Rv standard
sequence

rpfB M. tuberculosis H37Rv standard
sequence

Figure 2. Analysis of rpfB Recombinant Sequences Comparing to M. tuberculosis H37Rv Standard Sequence
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To examine the expression of RpfB, we performed
western blotting with an anti-GST antibody as reporter.
The results support previous data that the expressed
protein is a fusion between RpfB and GST (Figure 4).
The result of this experiment, using pellet and supernatant fractions, demonstrated that the protein was expressed mostly in the pellet. This indicates that the rpfB
gene may have been translated as inclusion bodies in E.
coli. To confirm that the protein expression of RpfB was
not in inclusion bodies as a result of the high culture
incubation temperature (37 °C), we repeated the culture
step with incubation temperature variations up to 20 °C
and examined the protein expression (data not shown).
The result reveals that the RpfB protein consistently
translates as inclusion bodies.
RpfB protein isolation, using the solubilization and
refolding solution containing urea, transferred the protein
originally in the pellet fraction to be in supernatant.
Modifying this fraction means that the proteins can be
isolated using an affinity column (Figure 5). Although
the refolding was successful, the amount of isolated
protein was nonetheless not optimal, as RpfB cit can be
seen from the amount of target protein observed in the
flow through. We speculate that the content of urea in
the solubilization and refolding solution possibly
blocked the binding of the GST protein to the slurry.

a. SDS PAGE
M

1

KDa

M

1

2

3

4

5

159

6

70
62

29

Figure 3. RpfB Expression on SDS PAGE. M = Marker;
1. E. coli BL21+pGEX-rpfB (H37Rv) without
Induction, 2. E. coli BL21+pGEX-rpfB (H37Rv)
was Inducted by 1 mM IPTG, 3. E. coli
BL21+pGEX-rpfB (Beijing) without Induction,
4. E. coli BL21+pGEX-rpfB (Beijing) was
Inducted by 1 mM IPTG, 5. E. coli BL21+pGEX
without Induction, 6. E. coli BL21+pGEX was
Inducted by 1 mM IPTG. Black Arrow Show
Expression of GST+RpfB, White Arrow Show
Expression of GST. Molecular Weight GST = 26
KDa, GST+RpfB = 64 KDa.

b. Western blotting
2

3

4

5

M

1

2

3

4

5

Figure 4. Confirmation of RpfB Protein Expression. a) SDS PAGE: Lane 1, BL21+pGEX 6P-1; Lane 2 BL21+pGEX-rpfB
(H37Rv) Pellet, Lane 3 BL21+pGEX-rpfB (H37Rv) Supernatant; Lane 4 BL21+pGEX-rpfB (Beijing) Pellet, Lane
5 BL21+pGEX-rpfB (Beijing) Supernatant. White Arrow Show Expression of GST Protein, Black Arrow Show
Expression of GST+RpfB. b). Western Blotting with Antibody-Anti GST: Lane 1, BL21+pGEX 6P-1; Lane 2
BL21+pGEX-rpfB (H37Rv) Pellet, Lane 3 BL21+pGEX-rpfB (H37Rv) Supernatant; Lane 4 BL21+pGEX-rpfB
(Beijing) Pellet, Lane 5 BL21+pGEX-rpfB (Beijing) Supernatant. White Arrow Show Expression of GST Protein,
Black Arrow Show Expression of GST+RpfB.
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1
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Figure 5. Isolation of RpfB Protein After Solubilizing and Refolding. Lane 1, Supernatant in Urea 8 M; Lane 2, Flow Trough;
Lane, 3-4, wash; Lane 5-8, Elute; Lane 9, GST Protein; M = Marker, Black Arrow Show Expression of GST+RpfB.

Further research in protein expression system testing is
needed to determine an efficient system in protein expression. In this study, we succeeded in cloning and
expressing one gene from the rpf family, rpfB, into the
pGEX system. However, analysis of the sequencing
results exhibited two point mutations in the gene clone
area. These mutations may alter the structure of the
RpfB protein strain from Beijing. Analysis of the
epitopes of CD4+ and CD8+ T cells demonstrated that
the amino acid change occurred outside the epitope
recognition of CD4+ and CD8+ T cells. Recognition of
CD4+ and CD8+ epitopes to be important on TB vaccine study caused by protection against tuberculosis
infection is generally mediated by IFγ and IL-12 that are
secreted by CD4+ and CD8+ [14]. All of these mutations likely have no effect on the RpfB antigenicity
properties. Changes in two amino acids, as a result of
gene mutations that still allow RpfB protein, can be
expressed in E. coli BL21. Results of the protein expression were detected by SDS PAGE, and demonstrated that the efficiency of protein expression RpfB in the
mutant clone is better than the control strain (H37Rv).
We suspect that these two amino acid changes supports
the efficiency of the expression of the protein. Further
testing is required to better understand the involvement
of these mutations in RpfB expression. Nevertheless, we
think it is this unexpected finding that will foster protein
production for our next study, one in further exploring
antigenicity of RpfB protein.
We expected that fusion of RpfB with GST proteins
would increase the solubility RpfB. In fact the expression of this protein, always in pellet fraction, indicates
that the protein was in inclusion body form. To confirm
RpfB protein expression was not in inclusion bodies due
to the high incubation temperature (37 °C) or IPTG, we
Makara J. Sci.

repeated the culture step with variation of IPTG concentration and incubation temperature variations below 37
°C (data not shown). Variation of IPTG concentration
and temperature did not appear to solubilize these proteins, and the results reveal that the RpfB protein is
translated as inclusion bodies. We do not have an argument to explain this phenomena, but it is possible that
the tac promoter in this vector might induce overexpression of proteins. Several other factors may result in the
formation of inclusion bodies, such as pH level,
osmolarity, cofactors, or folding mechanisms. Conversely, high expression levels also induce polypeptide
production in higher concentrations and would interact
with a similar region causing an inclusion body [15].
Although it is possible to isolate the target proteins from
the purify-native antigen of M. tuberculosis, expression
of the proteins on the host, such as E. coli, will be more
efficient and safe [16,17]. More than that, through this
method the target protein can be re-designed or reassembled with other target proteins [18].
Some expression vectors have also been developed and
used to obtain the target proteins. The pET system, containing the T7 promoter, has been used for the expression and isolation of M. tuberculosis proteins [18]. This
system is very popular, with more than 50% of cases of
successful protein expression with other bacteria [19].
Nevertheless, our other studies demonstrated that protein isolation using this vector is not able to distinguish
between the target and non-target protein on a western
blot (unpublished data). We suspect an anti-His antibody was cross-reacted with non-target proteins of E.
coli containing His residue that could not be separated
with an affinity column. Research conducted to study
the pET system expressed M. tuberculosis proteins and
show this system has successfully performed expression
December 2018 Vol. 22  No. 4
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and purification of target proteins. When the detection
of protein recombinants were observed using mass spectrometry, it is a more sensitive and expensive process
that requires more trained people compared to the conventional western blot method that we used [18]. However, there is a successful study that expressed M. tuberculosis protein in pDE22 plasmid, inserted with sequences that encode His’s-tag protein upstream of the
target gene [20]. This study is important information for
His use as there is a tag protein where the results differ
from our study. Several plasmids are also generally used
to express the protein, but have some weaknesses that
can be covered by the pGEX system. For example, under the control of the promoter cspA, the expression of
proteins requires lowering incubation temperature of the
cell culture [21], while the expression of the protein
under the control of the promoter λcI857 need a temperature up to 42 C [22,23].
Finally, the pGEX system has proven useful for cloning
and expression of M. tuberculosis proteins. This system
appears suitable for isolating M. tuberculosis proteins
that form inclusion bodies, and is easily refolded and resolubilized. Our study provides necessary information for
the expression and isolation of M. tuberculosis proteins.
The successful application of the pGEX system and the
modified method for protein isolation in this study can
be used by other researchers to assess the expression
and isolation of other M. tuberculosis target proteins.
Moreover, isolated protein from this study can then be
used for cellular immunogenicity assay to determine the
necessary immunogenic properties and can aid in the
discovery of new tuberculosis vaccine candidates.

Conclusion
RpfB protein of M. tuberculosis was successfully cloned,
expressed, and isolated in pGEX system. The expression
of RpfB as membrane protein, this target protein was
successfully isolated using the urea method.
Ethical clearance. This study is part of a study under
ethical clearence from the Ethics Committee of the Faculty
of Medicine Universitas Indonesia No. 906/UN2.F1/
ETHICS/2014.

Acknowledgments
This research was fund by Hibah Kompetitif DIKTI
2014-2016.

References
[1] Global tuberculosis report 2013 [internet]. World
Health Organization. Available from http://apps.
who.int/iris/bitstream/10665/91355/1/978924156465
6_eng.pdf.

Makara J. Sci.

161

[2] Svenson, K., Kallenius, G., Pawloski, A., Hamasur,
B. 2010. Towards new tuberculosis vaccines. Hum.
Vaccin. 6(4): 309–317.
[3] Thaiss, C.A., Kaufmann, S.H.E. 2010. Review, toward
of novel vaccines against tuberculosis: current
hopes and obstacles. Yale. J. Biol. Med. 83(4):
209–215.
[4] Russell, G.E., Xu, J., Wang, X., Chan, J.,
Tufariello, J.M. 2008. A Mycobacterium tuberculosis Rpf double-knockout strain exhibits profound
defects in reactivation from chronic tuberculosis
and innate immunity phenotypes. Infect. Immun.
76(9): 4269–4281.
[5] Kana, B.D., Downing, K.J., Gordhan, B.,
Vostroktunova, G., Sung, N., Vostroktunova, G., et
al. 2008. The resuscitation promoting factors of
Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in vitro. Mol
Microbiol. 67(3): 672–684.
[6] Yeremee, V.V., Kondratieva, T.K., Rubakova, E.I.,
Petrovskaya, S.N., Kazarian, K.A., Telkov, M.V.,
et al. 2003. Proteins of the Rpf family: Immune cell
reactivity and vaccination efficacy against tuberculosis in mice. Infect. Immun. 71(8): 4789–4794.
[7] Romano, M., Aryan, E., Korf, H., Bruffaerts, N.,
Franken, C.L., Ottenhoff, T.H., Huygen, K. 2012.
Potential of Mycobacterium tuberculosis resuscitation-promoting factors as antigens in novel tuberculosis sub-unit vaccines. Microbes. Infect. 14(1):
86–95.
[8] Li, D., Zhang, C., Lu, N., Mu, L., He, Y., Xu, L., et
al. 2014. Cloning and characterization of Clp protease proteolytic subunit 2 and its implication in
clinical diagnosis of tuberculosis. Int. J. Clin. Exp.
Pathol. 7(9): 5674-82.
[9] Yang, S., Zhang, F., Kang, J., Zhang, W., Deng,
G., Xin, Y., Ma, Y. 2014. Mycobacterium tuberculosis Rv1096 protein: gene cloning, protein expression, and peptidoglycan deacetylase activity. BMC
Microbiol. 14(1): 174.
[10] Cantoni, R., Branzoni, M., Labo, M., Riccardi, G.
1998. The MTCY428.08 gene of Mycobacterium
tuberculosis codes for NAD+ synthetase. J
Bacteriol. 180(12): 3218–3221.
[11] Aldous, W.K., Founder, J.I., Cloud, J.L., Woods, G.L.
2005. Comparison of Six Methods of Extracting
Mycobacterium tuberculosis DNA from Processed
Sputum for Testing by Quantitative Real-Time
PCR. J. Clin. Microbiol. 43(5): 2471–2473.
[12] Sambrook, J., Fritsch, E.F., Maniatis, T. 1989.
Molecular cloning, 2nd ed. Cold Spring Harbor
Laboratory Press.
[13] Mycobacterium tuberculosis strain H37Rv GenoList
browser [internet]. Institute Pasteur, France. 19992014. Available from: http://genolist.pasteur.fr/
TubercuList/index.html.

December 2018 Vol. 22  No. 4

162 Rukmana, et al.

[14] Caragol, I., Casanova, J.L. 2003. Inherited disorders
of the Interleukin-12/Interferon-gamma axis:
Mendelian predisposition to mycobacterial disease
in man. Immunol. 22(3): 263-276.
[15] Rosano, G.R., Ceccarelli, E.A. 2014. Recombinant
protein expression in Escherichia coli: advances
and challenges. Frontierts Microbiol. 5(172): 1-17.
[16] Ihssen, J., Kowarik, M., Dilettoso, S., Tanner, C.,
Wacker, M., Thöny-Meyer, L. 2010. Production of
glycoprotein vaccines in Escherichia coli. Microb.
Cell. Fact. 9: 61.
[17] Jong, W.S.P., Soprova, Z., de Punder, K., HagenJongman, C.M., Wagner, S., Wickström, D., de Gier,
J.W., Andersen, P., van der Wel, N.N., Luirink, J.
2012. A structurally informed autotrasporter platform for efficient heterologous protein secretion
and display. Microb. Cell. Fact. 11: 85.
[18] Luciano, P., Manuela, C., Caterina, T., Elisa, B.,
Francesca, M., Massimo, A., Marco, T., Flavia, M.,
Loredano, P. 2013. Optimizing Escherichia coli as
a protein expression platform to produce Mycobacterium tuberculosis immunogenic proteins.
Microbiol. Cell. Fact. 12(1): 115.

Makara J. Sci.

[19] Graumann, K., Premstaller, A. 2016. Manufacturing
of recombinant therapeutic proteins in microbial
systems. Biotechnol. J. 1(2): 164–186.
[20] Xue, Y., Bai, Y., Gaob, X., Jiang, H., Wang, L.,
Gao, H,. Xu Z. 2012. Expression, purification and
characterization of Mycobacterium tuberculosis
RpfE protein. J. Biomed. Res. 26(1): 17-23.
[21] Vasina, J.A., Peterson, M.S., Baneyx, F. 1998.
Scale-up low-temperature inducible cspA promoter
system. Biotechnol. Prog. 14(5): 714–721.
[22] Menart, V., Jevsevar, S., Vilar, M., Trobis, A.,
Pavko, A. 2003. Constitutive versus thermo inducible expression of heterologous proteins in Escherichia coli based on strong PR, PL promoters from
phage lambda. Biotechnol. Bioeng. 83(2): 181–190.
[23] Valdez-Cruz, N.A., Caspeta, L., Perez, N.O.,
Ramirez, O.T., Trujillo-Roldan, M.A. 2010. Production of recombinant proteins in E. coli by the
heat inducible expression system based on the
phage lambda pL and/or pR promoters. Microb.
Cell. Fact. 9: 18.

December 2018 Vol. 22  No. 4

